image
Coherus BioSciences, Inc. CHRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.06
-5.36 %
$ 123 M
Market Cap
4.24
P/E
BALANCE SHEET
449 M ASSETS
-28.76%
Growth Rates
1Year -28.76%
3Years -12.92%
5Years 1.87%
7Years 15.60%
10Years 9.13%
581 M LIABILITIES
-29.47%
Growth Rates
1Year -29.47%
3Years -0.06%
5Years 13.83%
7Years 23.55%
10Years 17.03%
-132 M EQUITY
31.76%
Growth Rates
1Year 31.76%
3Years -32.96%
5Years -17.65%
7Years -26.98%
10Years -11.53%
BALANCE SHEET DECOMPOSITION
Balance Sheet Coherus BioSciences, Inc.
image
Current Assets 342 M
Cash & Short-Term Investments 126 M
Receivables 122 M
Other Current Assets 93.3 M
Non-Current Assets 107 M
Long-Term Investments 0
PP&E 2.84 M
Other Non-Current Assets 104 M
28.09 %27.27 %20.79 %23.21 %Total Assets$448.5m
Current Liabilities 283 M
Accounts Payable 28.5 M
Short-Term Debt 0
Other Current Liabilities 255 M
Non-Current Liabilities 298 M
Long-Term Debt 232 M
Other Non-Current Liabilities 66 M
4.90 %43.84 %39.88 %11.37 %Total Liabilities$580.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 126.0 102.9 63.5 417.2 541.2 177.7 72.4 126.9 124.9 158.2 150.4 39.6 14.5
Short Term Investments 0 14.9 128.1 0 0 0 0 0 0 0 0 0 0
Receivables 122.3 260.5 110.0 123.0 157.0 142.0 0 0 1.9 1.6 4.2 0.4 0.2
Inventory 70.1 62.6 115.1 93.3 92.2 55.1 1.7 0 (4.8) (4.4) (8.2) 1 10.0
Other Current Assets 23.2 34.8 40.8 24.5 25.0 13.5 10.4 18.6 34.7 37.6 24.5 5.7 10.1
Total Current Assets 341.6 475.6 416.7 633.5 790.4 374.7 72.4 126.9 124.9 158.2 150.4 45.7 24.8
PP&E 2.8 11.0 8.8 7.8 20.1 16.5 6.7 12.8 10.8 10.5 4.5 1.7 1.6
Intangible Assets 53.6 70.7 5.0 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 0 0
Goodwill 0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0 0
Long Term Investments 0 0 0.4 0.4 0.4 0.2 0.8 0.8 0.8 0.8 0 0 0
Other Long Term Assets 50.5 71.3 49.5 34.5 27.6 14.1 16.9 19.4 39.2 40.1 28.8 27 K 0.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 448.5 629.6 480.8 679.3 841.6 408.9 99.5 162.6 178.5 212.4 187.2 47.4 26.5
LIABILITIES
Accounts Payable 28.5 35.2 11.5 16.2 15.2 26.0 15.3 15.7 20.6 29.5 10.8 3.7 3.9
Short Term Debt 0 2.1 4.3 3.5 3.1 2.2 0 0 0 0 0 4.2 1.7
Other Current Liabilities 254.5 294.4 122.8 145.7 127.3 86.8 18.0 12.7 33.8 25.6 41.0 31.5 3.6
Total Current Liabilities 283.0 331.8 54.5 79.0 81.5 115.0 33.3 28.4 56.4 106.0 51.8 53.7 11.3
Long Term Debt 231.5 478.7 476.1 415.5 414.0 188.6 103.1 101.6 100.3 0 0 0 0
Deferred Tax Income 1.1 1.1 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 64.9 11.5 3.5 0.8 1.1 0.1 1.7 2.1 1.8 68.0 28.8 7.6 12 K
Total Liabilities 580.5 823.0 618.3 581.6 560.7 303.7 138.1 132.1 159.1 219.3 120.5 89.8 17.3
EQUITY
Common Stock 12 K 11 K 8 K 7 K 7 K 7 K 7 K 6 K 5 K 4 K 3 K 1 K 1 K
Retained Earnings (1 551.0) (1 579.5) (1 341.6) (1 049.9) (762.8) (895.0) (984.8) (775.5) (537.3) (410.0) (186.7) (99.6) (46.0)
Other Accumulative Comprehensive Income/Loss (0.3) (0.2) (0.2) (0.3) (0.3) (0.6) (0.3) (0.8) (0.6) (0.4) (0.5) (0.6) (0.2)
Total Equity (132.0) (193.4) (137.4) 97.7 281.0 105.2 (38.6) 29.2 18.2 (7.7) 66.7 (42.4) 9.2
Total Liabilities and Equity 448.5 629.6 480.8 679.3 841.6 408.9 99.5 162.6 178.5 212.4 187.2 47.4 26.5
SHARES OUTSTANDING
Common Shares Outstanding 114.6 94.2 77.6 75.4 71.4 69.7 65.0 53.1 41.9 37.1 8.2 18.1 18.1